Carbon monoxide attenuates dextran sulfate sodium-induced colitis via inhibition of GSK-3 andbeta; Signaling

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Uddin, Md Jamal ^a   Jeong, Sun Oh ^a   Zheng, Min ^a,b   Chen, Yingqing ^a   Cho, Gyeong Jae ^c   Chung, Hun Taeg ^a   Joe, Yeonsoo ^a  

^a University of Ulsan   (South Korea)

^b YANBIAN UNIVERSITY   (China)

^c Gyeongsang National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; MAMMALS; PORPHYRINS;

DEXTRAN SULFATES; EFFECT OF CO; EFFECTS OF CO; HEME OXYGENASE-1; INFLAMMATORY BOWEL DISEASE; MOLECULAR MECHANISM; PRO-INFLAMMATORY CYTOKINES; ULCERATIVE COLITIS;

DISEASES;

CARBON MONOXIDE; DEXTRAN SULFATE; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BONE MARROW CELL; CELL SURVIVAL; COLITIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; INTRACELLULAR SIGNALING; LYMPH NODE CELL; MACROPHAGE; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CELL LINE; CHEMICALLY INDUCED DISORDER; COLON; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; LYMPH NODE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SURVIVAL;

MUS;

ANIMALS; BODY WEIGHT; BONE MARROW CELLS; CARBON MONOXIDE; CELL LINE; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INFLAMMATION MEDIATORS; LYMPH NODES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84890097058     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/210563     Document Type: Article

References (45)

1. Fiocchi C., Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998 115 1 182 205 2-s2.0-0031781603 10.1016/S0016-5085(98) 70381-6 (Pubitemid 28307304)
2. Xavier R. J., Podolsky D. K., Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007 448 7152 427 434 2-s2.0-34547176642 10.1038/nature06005 (Pubitemid 47123518)
3. Lawrence T., Bebien M., Liu G. Y., Nizet V., Karin M., IKK andagr; limits macrophage NF- B activation and contributes to the resolution of inflammation. Nature 2005 434 7037 1138 1143 2-s2.0-17844386319 10.1038/nature03491 (Pubitemid 40663493)
4. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R., A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990 98 3 694 702 2-s2.0-0025181580 (Pubitemid 20069706)
5. Yamada Y., Marshall S., Specian R. D., Grisham M. B., A comparative analysis of two models of colitis in rats. Gastroenterology 1992 102 5 1524 1534 2-s2.0-0026575942
6. Ryter S. W., Morse D., Choi A. M. K., Carbon monoxide and bilirubin: potential therapies for pulmonary/vascular injury and disease. American Journal of Respiratory Cell and Molecular Biology 2007 36 2 175 182 2-s2.0-33846914864 10.1165/rcmb.2006-0333TR (Pubitemid 46233470)
7. Hegazi R. A. F., Rao K. N., Mayle A., Sepulveda A. R., Otterbein L. E., Plevy S. E., Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. The Journal of Experimental Medicine 2005 202 12 1703 1713 2-s2.0-29144489192 10.1084/jem.20051047 (Pubitemid 41815876)
8. Sheikh S. Z., Hegazi R. A., Kobayashi T., Onyiah J. C., Russo S. M., Matsuoka K., Sepulveda A. R., Li F., Otterbein L. E., Plevy S. E., An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis. Journal of Immunology 2011 186 9 5506 5513 2-s2.0-79955544009 10.4049/jimmunol.1002433
9. Nakao A., Toyokawa H., Abe M., Kiyomoto T., Nakahira K., Choi A. M. K., Nalesnik M. A., Thomson A. W., Murase N., Heart allograft protection with low-dose carbon monoxide inhalation: effects on inflammatory mediators and alloreactive T-cell responses. Transplantation 2006 81 2 220 230 2-s2.0-33644850833 10.1097/01.tp.0000188637.80695.7f
10. Kohmoto J., Nakao A., Stolz D. B., Kaizu T., Tsung A., Ikeda A., Shimizu H., Takahashi T., Tomiyama K., Sugimoto R., Choi A. M. K., Billiar T. R., Murase N., McCurry K. R., Carbon monoxide protects rat lung transplants from ischemia-reperfusion injury via a mechanism involving p38 MAPK pathway. American Journal of Transplantation 2007 7 10 2279 2290 2-s2.0-34548331673 10.1111/j.1600-6143.2007.01940.x (Pubitemid 47347863)
11. Goebel U., Siepe M., Mecklenburg A., Stein P., Roesslein M., Schwer C. I., Schmidt R., Doenst T., Geiger K. K., Pahl H. L., Schlensak C., Loop T., Carbon monoxide inhalation reduces pulmonary inflammatory response during cardiopulmonary bypass in pigs. Anesthesiology 2008 108 6 1025 1036 2-s2.0-45149084968 10.1097/ALN.0b013e3181733115
12. Cepinskas G., Katada K., Bihari A., Potter R. F., Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. American Journal of Physiology: Gastrointestinal and Liver Physiology 2008 294 1 G184 G191 2-s2.0-38349171767 10.1152/ajpgi.00348.2007
13. Minamino T., Christou H., Hsieh C.-M., Liu Y., Dhawan V., Abraham N. G., Perrella M. A., Mitsialis S. A., Kourembanas S., Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proceedings of the National Academy of Sciences of the United States of America 2001 98 15 8798 8803 2-s2.0-0035902447 10.1073/pnas.161272598 (Pubitemid 32678107)
14. Sawle P., Foresti R., Mann B. E., Johnson T. R., Green C. J., Motterlini R., Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. The British Journal of Pharmacology 2005 145 6 800 810 2-s2.0-23044459608 10.1038/sj.bjp.0706241 (Pubitemid 41076287)
15. Takagi T., Naito Y., Uchiyama K., Suzuki T., Hirata I., Mizushima K., Tsuboi H., Hayashi N., Handa O., Ishikawa T., Yagi N., Kokura S., Ichikawa H., Yoshikawa T., Carbon monoxide liberated from carbon monoxide-releasing molecule exerts an anti-inflammatory effect on dextran sulfate sodium-induced colitis in mice. Digestive Diseases and Sciences 2011 56 6 1663 1671 2-s2.0-79959699593 10.1007/s10620-010-1484-y
16. Ali A., Hoeflich K. P., Woodgett J. R., Glycogen synthase kinase-3: properties, functions, and regulation. Chemical Reviews 2001 101 8 2527 2540 2-s2.0-0035413614 10.1021/cr000110o (Pubitemid 35373033)
17. Jope R. S., Johnson G. V. W., The glamour and gloom of glycogen synthase kinase-3. Trends in Biochemical Sciences 2004 29 2 95 102 2-s2.0-0442276554 10.1016/j.tibs.2003.12.004 (Pubitemid 38186580)
18. Frame S., Cohen P., GSK3 takes centre stage more than 20 years after its discovery. The Biochemical Journal 2001 359 1 1 16 2-s2.0-0035477020 10.1042/0264-6021:3590001 (Pubitemid 32939202)
19. Whittle B. J. R., Varga C., Poandacute;sa A., Molnaandacute;r A., Collin M., Thiemermann C., Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3 andbeta; British Journal of Pharmacology 2006 147 5 575 582 2-s2.0-33644829249 10.1038/sj.bjp.0706509 (Pubitemid 43355056)
20. Ndisang J. F., Lane N., Jadhav A., Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes. American Journal of Physiology: Endocrinology and Metabolism 2009 296 5 E1029 E1041 2-s2.0-66149135526 10.1152/ajpendo.90241.2008
21. Chambers T. J., Owens J. M., Hattersley G., Jat P. S., Noble M. D., Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse. Proceedings of the National Academy of Sciences of the United States of America 1993 90 12 5578 5582 2-s2.0-0027285358 (Pubitemid 23176204)
22. Marques V. P., Goncandcedil;alves G. M., Feitoza C. Q., Cenedeze M. A., Fernandes Bertocchi A. P., Damiaandtild;o M. J., Pinheiro H. S., Antunes Teixeira V. P., Dos Reis M. A., Pacheco-Silva A., Saraiva Caandcirc;mara N. O., Influence of TH1/TH2 switched immune response on renal ischemia-reperfusion injury. Nephron Experimental Nephrology 2006 104 1 e48 e56 2-s2.0-33747265171 10.1159/000093676
23. Blackwell T. S., Christman J. W., The role of nuclear factor- B in cytokine gene regulation. American Journal of Respiratory Cell and Molecular Biology 1997 17 1 3 9 2-s2.0-0031183766 (Pubitemid 127500814)
24. Martin M., Rehani K., Jope R. S., Michalek S. M., Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nature Immunology 2005 6 8 777 784 2-s2.0-23944486750 10.1038/ni1221 (Pubitemid 43090463)
25. Demarchi F., Bertoli C., Sandy P., Schneider C., Glycogen synthase kinase-3 andbeta; regulates NF- B1/p105 stability. The Journal of Biological Chemistry 2003 278 41 39583 39590 2-s2.0-0141928780 10.1074/jbc.M305676200 (Pubitemid 37258323)
26. Badger A. M., Bradbeer J. N., Votta B., Lee J. C., Adams J. L., Griswold D. E., Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. The Journal of Pharmacology and Experimental Therapeutics 1996 279 3 1453 1461 2-s2.0-0030426902 (Pubitemid 27166795)
27. Spittler A., Razenberger M., Kupper H., Kaul M., Hackl W., Boltz-Nitulescu G., Fuanddie;gger R., Roth E., Relationship between interleukin-6 plasma concentration in patients with sepsis, monocyte phenotype, monocyte phagocytic properties, and cytokine production. Clinical Infectious Diseases 2000 31 6 1338 1342 2-s2.0-0034573399
28. Morse D., Pischke S. E., Zhou Z., Davis R. J., Flavell R. A., Loop T., Otterbein S. L., Otterbein L. E., Choi A. M. K., Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. The Journal of Biological Chemistry 2003 278 39 36993 36998 2-s2.0-0141707960 10.1074/jbc.M302942200 (Pubitemid 37175212)
29. Moore B. A., Otterbein L. E., Tuanddie;rler A., Choi A. M. K., Bauer A. J., Inhaled carbon monoxide suppresses the development of postoperative ileus in the murine small intestine. Gastroenterology 2003 124 2 377 391 2-s2.0-0037311150 10.1053/gast.2003.50060 (Pubitemid 36169255)
30. Wagener F. A. D. T. G., Da Silva J.-L., Farley T., De Witte T., Kappas A., Abraham N. G., Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule expression. The Journal of Pharmacology and Experimental Therapeutics 1999 291 1 416 423 2-s2.0-0032881831 (Pubitemid 29451618)
31. Nakao A., Kimizuka K., Stolz D. B., Neto J. S., Kaizu T., Choi A. M. K., Uchiyama T., Zuckerbraun B. S., Nalesnik M. A., Otterbein L. E., Murase N., Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. The American Journal of Pathology 2003 163 4 1587 1598 2-s2.0-0141760341 (Pubitemid 37175105)
32. Neto J. S., Nakao A., Kimizuka K., Romanosky A. J., Stolz D. B., Uchiyama T., Nalesnik M. A., Otterbein L. E., Murase N., Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. American Journal of Physiology: Renal Physiology 2004 287 5 F979 F989 2-s2.0-6344237408 10.1152/ajprenal.00158.2004 (Pubitemid 39391095)
33. Uchiyama K., Naito Y., Takagi T., Mizushima K., Hayashi N., Harusato A., Hirata I., Omatsu T., Handa O., Ishikawa T., Yagi N., Kokura S., Yoshikawa T., Carbon monoxide enhance colonic epithelial restitution via FGF15 derived from colonic myofibroblasts. Biochemical and Biophysical Research Communications 2010 391 1 1122 1126 2-s2.0-72949105138 10.1016/j.bbrc.2009.12.035
34. Naito Y., Takagi T., Uchiyama K., Yoshikawa T., Heme oxygenase-1: a novel therapeutic target for gastrointestinal diseases. Journal of Clinical Biochemistry and Nutrition 2011 48 2 126 133 2-s2.0-79952409755 10.3164/jcbn.10-61
35. Xia Y., Rao J., Yao A., Zhang F., Li G., Wang X., Lithium exacerbates hepatic ischemia/reperfusion injury by inhibiting GSK-3beta/NF-kappaB-mediated protective signaling in mice. European Journal of Pharmacology 2012 697 1-3 117 125 10.1016/j.ejphar.2012.09.009
36. Platzer C., Fritsch E., Elsner T., Lehmann M. H., Volk H. D., Prosch S., Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells. European Journal of Immunology 1999 29 10 3098 3104 (Pubitemid 29484199)
37. Hu X., Paik P. K., Chen J., Yarilina A., Kockeritz L., Lu T. T., Woodgett J. R., Ivashkiv L. B., IFN- andgamma; Suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 Proteins. Immunity 2006 24 5 563 574 2-s2.0-33646595287 10.1016/j.immuni.2006.02.014 (Pubitemid 43728157)
38. Song Y.-A., Park Y.-L., Kim K.-Y., Chung C.-Y., Lee G.-H., Cho D.-H., Ki H.-S., Park K.-J., Cho S.-B., Lee W.-S., Kim N., Ahn B.-W., Joo Y.-E., Black tea extract prevents lipopolysaccharide-induced NF- B signaling and attenuates dextran sulfate sodium-induced experimental colitis. BMC Complementary and Alternative Medicine 2011 11, article 91 2-s2.0-80053651921 10.1186/1472-6882- 11-91
39. Villegas I., La Casa C., Orjales A., Alarcon de la Lastra C., Effects of dosmalfate, a new cytoprotective agent, on acute and chronic trinitrobenzene sulphonic acid-induced colitis in rats. European Journal of Pharmacology 2003 460 2-3 209 218 2-s2.0-0037462418 10.1016/S0014-2999(02)02949-7 (Pubitemid 36142056)
40. Takagi T., Naito Y., Mizushima K., Akagiri S., Suzuki T., Hirata I., Omatsu T., Handa O., Kokura S., Ichikawa H., Yoshikawa T., Inhalation of carbon monoxide ameliorates TNBS-induced colitis in mice through the inhibition of TNF- andagr; expression. Digestive Diseases and Sciences 2010 55 10 2797 2804 2-s2.0-77957913463 10.1007/s10620-009-1112-x
41. Sugimoto K., Ogawa A., Mizoguchi E., Shimomura Y., Andoh A., Bhan A. K., Blumberg R. S., Xavier R. J., Mizoguchi A., IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. The Journal of Clinical Investigation 2008 118 2 534 544 2-s2.0-38849141814 10.1172/JCI33194 (Pubitemid 351206544)
42. Berg D. J., Davidson N., Kuanddie;hn R., Muanddie;ller W., Menon S., Holland G., Thompson-Snipes L., Leach M. W., Rennick D., Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) Th1-like responses. The Journal of Clinical Investigation 1996 98 4 1010 1020 2-s2.0-0029813545 (Pubitemid 26293320)
43. Dugo L., Collin M., Allen D. A., Patel N. S. A., Bauer I., Mervaala E. M. A., Louhelainen M., Foster S. J., Yaqoob M. M., Thiemermann C., GSK-3 andbeta; inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat. Critical Care Medicine 2005 33 9 1903 1912 2-s2.0-24944567775 10.1097/01.CCM.0000178350.21839.44 (Pubitemid 41306508)
44. Cohen P., Frame S., The renaissance of GSK3. Nature Reviews Molecular Cell Biology 2001 2 10 769 776 2-s2.0-0035488986 10.1038/35096075 (Pubitemid 33679839)
45. Hofmann C., Dunger N., Schoanddie;lmerich J., Falk W., Obermeier F., Glycogen synthase kinase 3- andbeta;: a master regulator of toll-like receptor-mediated chronic intestinal inflammation. Inflammatory Bowel Diseases 2010 16 11 1850 1858 2-s2.0-78249233264 10.1002/ibd.21294